Literature DB >> 10947061

Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection.

M Kaji1, M Kobayashi, R B Pollard, F Suzuki.   

Abstract

The role of type 2 T cell responses on the severity of post-infectious encephalitis was investigated in a mouse model of influenza virus infection. When mice were infected intracerebrally with 3.0 LD(50) of A/NWS33 strain of influenza virus, they all showed clinical signs of encephalitis, and 90% of them died within 10 days of the infection. However, the post-infectious encephalitis was not demonstrated in mice exposed to 0.5 LD50 of the same virus. The mortality rates of mice infected with 0.5 LD(50) of the virus were increased to levels observed in mice exposed to 3.0 LD(50) of influenza virus infection, after the administration of a mixture of interleukin (IL)-4 and IL-10 (2 ng/mouse each; immediately, 1 and 2 days after the infection). In contrast, mortality rates of mice exposed to 3.0 LD(50) of influenza virus were substantially decreased when these mice were treated with a mixture of monoclonal antibodies directed against IL-4 and IL-10. A predominance of type 2 T cell responses was demonstrated in splenic T cells of mice infected with 3.0 LD(50) of influenza virus, although these responses were minimal in mice infected with 0.5 LD(50) of the virus. After the treatment with the mixture of type 2 cytokines, an increase in the type 2 T cell responses in mice exposed to 0.5 LD(50) of the virus was shown. These results indicate that type 2 T cell responses associated with the viral infection play an important role in the severity of post-infectious encephalitis induced in mice by the intracerebral infection of influenza A virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947061

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.

Authors:  Jae-Kwang Yoo; Carole L Galligan; Carl Virtanen; Eleanor N Fish
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.